RESUMEN
The research examined the impact of an ethanolic extract from the leaves of Kratom (Mitragyna speciosa (Korth.) Havil.) on the growth, antioxidant capacity, immune-related gene expression, and resistance to disease caused by Edwardsiella tarda in Nile tilapia (Oreochromis niloticus). The findings revealed that the extract had the important phytochemical content in the extract included total phenolics content, total flavonoids content, vitamin C, and total antioxidant capacity and 5.42 % of the crude extract was mitragynine. The extract demonstrated antioxidant activity, as evidenced by its IC50 values against ABTS and DPPH radicals and its ferric reducing power in vitro. Moreover, the MIC-IC50 value of 0.625 mg/mL indicated that the growth of the bacteria was reduced by approximately 50 %, and the MBC was 2.50 mg/mL against E. tarda. Furthermore, the orally administered Kratom leaf extract to fingerling tilapia for 8 weeks exhibited a noticeable increase in oxidative stress, as demonstrated by the increase in MDA production in the 10 and 25 g/kg groups. It also exhibited an increase in acetylcholinesterase (AChE) activity in muscle tissue at the 50 g/kg group. However, when administered at a feeding rate of 5-10 g/kg feed, the extract showed an increase in the expression of immune-related genes (IL1, IL6, IL8, NF-kB, IFNγ, TNFα, Mx, CC-chemokine, CD4, TCRß, MHC-IIß, IgM, IgT, IgD) and enhanced resistance to E. tarda infection in fish. Conversely, administering the extract at 25-50 g/kg feed resulted in contrasting effects, suppressing and reducing the observed parameters. Nevertheless, feeding the extract at all concentrations for 8 weeks did not produce any changes in the histology or systemic functioning of the liver and intestines, as indicated by blood biochemistry. These findings suggest that the ethanolic leaf extract from Kratom has the potential to be used as a substitute for antibiotics in the management of bacterial infections in Nile tilapia culture, with a recommended dosage of 5-10 g/kg feed/day for a maximum of 8 weeks.
Asunto(s)
Antibacterianos , Antioxidantes , Cíclidos , Edwardsiella tarda , Infecciones por Enterobacteriaceae , Enfermedades de los Peces , Mitragyna , Extractos Vegetales , Hojas de la Planta , Animales , Enfermedades de los Peces/inmunología , Extractos Vegetales/farmacología , Extractos Vegetales/química , Extractos Vegetales/administración & dosificación , Cíclidos/inmunología , Cíclidos/crecimiento & desarrollo , Edwardsiella tarda/efectos de los fármacos , Edwardsiella tarda/fisiología , Infecciones por Enterobacteriaceae/veterinaria , Infecciones por Enterobacteriaceae/inmunología , Antioxidantes/farmacología , Hojas de la Planta/química , Antibacterianos/farmacología , Mitragyna/química , Resistencia a la Enfermedad/efectos de los fármacos , Dieta/veterinaria , Alimentación Animal/análisis , Suplementos Dietéticos/análisisRESUMEN
The global surge in multidrug-resistant bacteria owing to antibiotic misuse and overuse poses considerable risks to human and animal health. With existing antibiotics losing their effectiveness and the protracted process of developing new antibiotics, urgent alternatives are imperative to curb disease spread. Notably, improving the bactericidal effect of antibiotics by using non-antibiotic substances has emerged as a viable strategy. Although reduced nicotinamide adenine dinucleotide (NADH) may play a crucial role in regulating bacterial resistance, studies examining how the change of metabolic profile and bacterial resistance following by exogenous administration are scarce. Therefore, this study aimed to elucidate the metabolic changes that occur in Edwardsiella tarda (E. tarda), which exhibits resistance to various antibiotics, following the exogenous addition of NADH using metabolomics. The effects of these alterations on the bactericidal activity of neomycin were investigated. NADH enhanced the effectiveness of aminoglycoside antibiotics against E. tarda ATCC15947, achieving bacterial eradication at low doses. Metabolomic analysis revealed that NADH reprogrammed the ATCC15947 metabolic profile by promoting purine metabolism and energy metabolism, yielding increased adenosine triphosphate (ATP) levels. Increased ATP levels played a crucial role in enhancing the bactericidal effects of neomycin. Moreover, exogenous NADH promoted the bactericidal efficacy of tetracyclines and chloramphenicols. NADH in combination with neomycin was effective against other clinically resistant bacteria, including Aeromonas hydrophila, Vibrio parahaemolyticus, methicillin-resistant Staphylococcus aureus, and Listeria monocytogenes. These results may facilitate the development of effective approaches for preventing and managing E. tarda-induced infections and multidrug resistance in aquaculture and clinical settings.
Asunto(s)
Aminoglicósidos , Antibacterianos , Edwardsiella tarda , NAD , Edwardsiella tarda/efectos de los fármacos , Antibacterianos/farmacología , NAD/metabolismo , Aminoglicósidos/farmacología , Animales , Enfermedades de los Peces/microbiología , Enfermedades de los Peces/tratamiento farmacológico , Pruebas de Sensibilidad Microbiana , Infecciones por Enterobacteriaceae/microbiología , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Adenosina Trifosfato/metabolismo , Neomicina/farmacología , Sinergismo Farmacológico , Metabolómica , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacosRESUMEN
The relationship between antibiotic resistance and bacterial virulence has not yet been fully explored. Here, we use Edwardsiella tarda as the research model to investigate the proteomic change upon oxytetracycline resistance (LTB4-ROTC). Compared to oxytetracycline-sensitive E. tarda (LTB4-S), LTB4-ROTC has 234 differentially expressed proteins, of which the abundance of 84 proteins is downregulated and 15 proteins are enriched to the Type III secretion system, Type VI secretion system, and flagellum pathways. Functional analysis confirms virulent phenotypes, including autoaggregation, biofilm formation, hemolysis, swimming, and swarming, are impaired in LTB4-ROTC. Furthermore, the in vivo bacterial challenge in both tilapia and zebrafish infection models suggests that the virulence of LTB4-ROTC is attenuated. Analysis of immune gene expression shows that LTB4-ROTC induces a stronger immune response in the spleen but a weaker response in the head kidney than that induced by LTB4-S, suggesting it's a potential vaccine candidate. Zebrafish and tilapia were challenged with a sublethal dose of LTB4-ROTC as a live vaccine followed by LTB4-S challenge. The relative percentage of survival of zebrafish is 60% and that of tilapia is 75% after vaccination. Thus, our study suggests that bacteria that acquire antibiotic resistance may attenuate virulence, which can be explored as a potential live vaccine to tackle bacterial infection in aquaculture.
Asunto(s)
Farmacorresistencia Bacteriana , Edwardsiella tarda , Infecciones por Enterobacteriaceae , Oxitetraciclina , Tilapia , Pez Cebra , Edwardsiella tarda/patogenicidad , Edwardsiella tarda/efectos de los fármacos , Edwardsiella tarda/genética , Animales , Oxitetraciclina/farmacología , Virulencia/efectos de los fármacos , Infecciones por Enterobacteriaceae/microbiología , Infecciones por Enterobacteriaceae/inmunología , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Tilapia/microbiología , Enfermedades de los Peces/microbiología , Enfermedades de los Peces/inmunología , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Proteómica/métodos , Vacunas Bacterianas/inmunologíaRESUMEN
The Oscar fish (Astronotus ocellatus) is among the most commonly domesticated and exported ornamental fish species from Kerala. The ornamental fish industry faces a significant challenge with the emergence of diseases caused by multi-drug-resistant bacteria. In the present study, six isolates were resolved from the diseased Oscar fish showing haemorrhages, necrosis, and loss of pigmentation. After phenotypic and genotypic characterization, the bacteria were identified as Edwardsiella tarda, Klebsiella pneumoniae, Enterococcus faecalis, Escherichia coli, Brevibacillus borstelensis, and Staphylococcus hominis. Experimental challenge studies in healthy Oscar fish showed that E. tarda caused 100% mortality within 240 h with 6.99 × 106 CFU/fish as LD50 and histopathology revealed the typical signs of infection. The pathogen was re-recovered from the moribund fish thereby confirming Koch's postulates. E. tarda was confirmed through the positive amplification of tarda-specific gene and virulence genes viz., etfD and escB were also detected using PCR. Antibiotic susceptibility tests using disc diffusion displayed that the pathogen is multi-drug-resistant towards antibiotics belonging to aminoglycosides, tetracyclines, and quinolones categories with a MAR index of 0.32, which implicated the antibiotic pressure in the farm. Plasmid curing studies showed a paradigm shift in the resistance pattern with MAR index of 0.04, highlighting the resistance genes are plasmid-borne except for the chromosome-borne tetracycline resistance gene (tetA). This study is the first of its kind in detecting mass mortality caused by E. tarda in Oscar fish. Vigilant surveillance and strategic actions are crucial for the precise detection of pathogens and AMR in aquaculture.
Asunto(s)
Antibacterianos , Farmacorresistencia Bacteriana Múltiple , Edwardsiella tarda , Infecciones por Enterobacteriaceae , Enfermedades de los Peces , Pruebas de Sensibilidad Microbiana , Animales , Enfermedades de los Peces/microbiología , Enfermedades de los Peces/mortalidad , Edwardsiella tarda/genética , Edwardsiella tarda/patogenicidad , Edwardsiella tarda/aislamiento & purificación , Edwardsiella tarda/efectos de los fármacos , Infecciones por Enterobacteriaceae/microbiología , Infecciones por Enterobacteriaceae/veterinaria , Infecciones por Enterobacteriaceae/mortalidad , Farmacorresistencia Bacteriana Múltiple/genética , Antibacterianos/farmacología , Peces/microbiología , Virulencia/genética , Factores de Virulencia/genéticaRESUMEN
Thirty- and 90-kDa proteins with binding ability to Edwardsiella tarda, a causative bacterium of Edwardsiellosis in fish, were purified from the embryo of Japanese flounder Paralichthys olivaceus. The proteins were isolated with affinity chromatography, in which the bacterium was used as a ligand and galactose, mannose, and ethylenediaminetetraacetic acid (EDTA) were used as elution agents, followed by gel filtration chromatography. N-terminal amino acid sequencing and liquid chromatography with quadrupole time-of-flight tandem mass spectrometry (LC/Q-TOF-MS) analysis revealed that the 90-kDa protein was lipovitellin heavy-chain (LvH), which is one of the proteolytically cleaved products of maternal vitellogenin (Vg) and represents the main precursor of the egg yolk in teleosts, and the 30-kDa protein was an N-terminal bit of LvH. On the other hand, Vg in the serum of the mother fish did not bind to E. tarda. While the 90-kDa protein did not show anti-bacterial activity, the 30-kDa protein strongly exhibited activity toward E. tarda, with a minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) below 0.06 µM, suggesting that the latter protein plays an important role during embryogenesis in the flounder. This is the first report showing that Vg-derived products have monosaccharides-binding activity and a fragment derived from LvH exhibits bactericidal activity.
Asunto(s)
Antibacterianos/farmacología , Edwardsiella tarda/efectos de los fármacos , Proteínas del Huevo/farmacología , Infecciones por Enterobacteriaceae/veterinaria , Lenguado/microbiología , Vitelogeninas/metabolismo , Secuencia de Aminoácidos , Animales , Edwardsiella tarda/crecimiento & desarrollo , Proteínas del Huevo/metabolismo , Enfermedades de los Peces/tratamiento farmacológico , Enfermedades de los Peces/microbiología , Proteínas de Peces/metabolismo , Lenguado/embriología , Pruebas de Sensibilidad Microbiana , Óvulo/citología , Espectrometría de Masas en TándemRESUMEN
Calreticulin (Crt) is a highly conserved and multi-functional protein with lectin-like properties and important immunological activities. In this study, a Crt homolog, namely, ToCrt, was cloned and characterized from the obscure puffer Takifugu obscurus with an open reading frame of 1278 bp encoding a putative protein of 425 amino acids. The deduced amino acid sequence of ToCrt consisted of three conserved structural domains: N-domain, P-domain, and C-terminal domain. In the phylogenetic tree, ToCrt formed a separate cluster with three Crts from other pufferfish species (Takifugu rubripes, Takifugu flavidus, and Takifugu bimaculatus). The mRNA transcript of ToCrt was ubiquitously expressed in all the examined tissues in a decreasing order: liver, spleen, kidney, gills, intestine, and heart. After Vibrio harveyi, Edwardsiella tarda, and Aeromonas hydrophila stimulations, the levels of ToCrt mRNA in the kidney and spleen were significantly upregulated compared with that in the control group. The recombinant calreticulin domain of ToCrt (rToCrt) could bind three Gram-negative bacteria (V. harveyi, E. tarda, and A. hydrophila) and polysaccharides from bacterial cell walls such as lipopolysaccharide and peptidoglycan. Meanwhile, rToCrt could agglutinate different kinds of microorganisms and exhibit antimicrobial activity. These results suggested that T. obscurus ToCrt could serve as an antimicrobial effector in the host immune response against invading microorganisms.
Asunto(s)
Antiinfecciosos/inmunología , Calreticulina/metabolismo , Inmunidad , Takifugu/inmunología , Aeromonas hydrophila/efectos de los fármacos , Aglutinación/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Antiinfecciosos/farmacología , Secuencia de Bases , Calreticulina/química , Calreticulina/genética , Calreticulina/aislamiento & purificación , Edwardsiella tarda/efectos de los fármacos , Perfilación de la Expresión Génica , Regulación de la Expresión Génica/efectos de los fármacos , Filogenia , Polisacáridos/metabolismo , Unión Proteica/efectos de los fármacos , Dominios Proteicos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Takifugu/microbiología , Factores de Tiempo , Vibrio/efectos de los fármacosRESUMEN
Two new phenol derivatives, namely insphenol A (1) and acetylpeniciphenol (2), along with seven known analogs (3-9), were isolated from the deep-sea cold seep-derived fungus, Aspergillus insuetus SD-512. The structures of 1 and 2 were established by extensive interpretation of NMR and mass spectroscopic data. The absolute configuration of 1 was determined by the combination of coupling constant analysis and acid hydrolysis. Among the isolated compounds, insphenol A (1) represents the first example of isopentenyl phenol derivative with a unique 1-glycosylation from the species Aspergillus insuetus. The isolated new compounds were evaluated for antibacterial activities against six human or aquatic pathogens, while compound 2 exhibited inhibitory effect against Edwardsiella tarda, Vibrio alginolyticus, and V.â vulnificus, with MIC values of 4, 8, and 8â µg/mL, respectively.
Asunto(s)
Antibacterianos/farmacología , Aspergillus/química , Edwardsiella tarda/efectos de los fármacos , Fenoles/farmacología , Vibrio/efectos de los fármacos , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Fenoles/química , Fenoles/aislamiento & purificaciónRESUMEN
Edwardsiella tarda can cause fatal gastro-/extraintestinal diseases in fish and humans. Overuse of antibiotics has led to antibiotic resistance and contamination in the environment, which highlights the need to find new antimicrobial agents. In this study, the marine peptide-N6 was amidated at its C-terminus to generate N6NH2. The antibacterial activity of N6 and N6NH2 against E. tarda was evaluated in vitro and in vivo; their stability, toxicity and mode of action were also determined. Minimal inhibitory concentrations (MICs) of N6 and N6NH2 against E. tarda were 1.29-3.2 µM. Both N6 and N6NH2 killed bacteria by destroying the cell membrane of E. tarda and binding to lipopolysaccharide (LPS) and genomic DNA. In contrast with N6, N6NH2 improved the stability toward trypsin, reduced hemolysis (by 0.19% at a concentration of 256 µg/mL) and enhanced the ability to penetrate the bacterial outer and inner membrane. In the model of fish peritonitis caused by E. tarda, superior to norfloxacin, N6NH2 improved the survival rate of fish, reduced the bacterial load on the organs, alleviated the organ injury and regulated the immunity of the liver and kidney. These data suggest that the marine peptide N6NH2 may be a candidate for novel antimicrobial agents against E. tarda infections.
Asunto(s)
Antibacterianos/farmacología , Péptidos Catiónicos Antimicrobianos/farmacología , Edwardsiella tarda/efectos de los fármacos , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Infecciones por Enterobacteriaceae/virología , Enfermedades de los Peces/tratamiento farmacológico , Animales , Antibacterianos/química , Péptidos Catiónicos Antimicrobianos/química , Membrana Celular/efectos de los fármacos , Infecciones por Enterobacteriaceae/microbiología , Enfermedades de los Peces/microbiología , Enfermedades de los Peces/patología , Proteínas de Peces , Riñón/patología , Hígado/patología , Pruebas de Sensibilidad Microbiana , Norfloxacino/uso terapéutico , Peritonitis/tratamiento farmacológico , Peritonitis/etiología , Relación Estructura-Actividad , Análisis de SupervivenciaRESUMEN
We investigated the antimicrobial properties and the effects of Rheum officinale extract (ROE) on nonspecific immune parameters of orange-spotted grouper (Epinephelus coioides) in vitro and in vivo. The in vitro analysis was conducted by treating grouper primary head kidney leukocytes with various concentrations of ROE. The phagocytic rate of the leukocytes was elevated in a dose-dependent manner from 0.01 to 0.1 mg/ml, but decreased with higher concentrations of ROE (0.5 and 1.0 mg/ml). The production of reactive oxygen species (ROS) was strongly enhanced in a dose-dependent manner by treatment with ROE doses of 0.1-10.0 mg/ml. However, morphological changes (e.g., rounding and shrinkage of cells, chromatin condensation, fragmentation, and appearance of apoptotic bodies) were observed in the leukocytes after incubation with higher concentrations of ROE (1.0 and 10.0 mg/ml). A 28-day feeding trial was performed to assess the impact of dietary administration of ROE on grouper innate immunity parameters. Fish were fed with feed supplemented with 0, 0.1, 1.0, or 5.0 g ROE per kg of feed. The phagocytic activity of the animals' leukocytes was significantly elevated in all ROE-fed groups on day 1 and in groups fed with ROE at 0.1 or 1.0 g/kg on day 14. Production of ROS was substantially increased on day 1 in fish fed with ROE at 1.0 and 5.0 g/kg, but decreased steadily later on. The ability to generate ROS increased steadily until day 7 in fish fed the lowest concentration of ROE (0.1 mg/ml), but decreased thereafter. ROE showed excellent antibacterial activity against six pathogens of aquatic animals: Vibrio parahaemolyticus, V. vulnificus, V. alginolyticus, V. carchariae, Aeromonas hydrophila, and Edwardsiella tarda. The minimum inhibitory and bactericidal concentrations of measured ROE-derived anthraquinones were 10.57-84.53 µg/ml and 10.57-169.05 µg/ml, respectively.
Asunto(s)
Antibacterianos/farmacología , Lubina/inmunología , Enfermedades de los Peces/inmunología , Inmunidad Innata , Extractos Vegetales/farmacología , Rheum/química , Aeromonas hydrophila/efectos de los fármacos , Animales , Edwardsiella tarda/efectos de los fármacos , Infecciones por Enterobacteriaceae/inmunología , Infecciones por Enterobacteriaceae/microbiología , Infecciones por Enterobacteriaceae/veterinaria , Enfermedades de los Peces/microbiología , Infecciones por Bacterias Gramnegativas/inmunología , Infecciones por Bacterias Gramnegativas/microbiología , Infecciones por Bacterias Gramnegativas/veterinaria , Inmunidad Innata/efectos de los fármacos , Extractos Vegetales/química , Vibrio/efectos de los fármacos , Vibriosis/inmunología , Vibriosis/veterinariaRESUMEN
Two new antimicrobial bisabolane-type sesquiterpenoid derivatives, ent-aspergoterpenin C (compound 1) and 7-O-methylhydroxysydonic acid (2), and two new butyrolactone-type monoterpenoids, pestalotiolactones C (3) and D (4), along with a known monoterpenoid pestalotiolactone A (5) and four known bisabolane sesquiterpenoids (6-9), were isolated and identified from the deep-sea sediment-derived fungus Aspergillus versicolor SD-330. The structures of these compounds were elucidated on the basis of spectroscopic analysis, and the absolute configurations of the new compounds 1-4 were determined by the combination of NOESY and TDDFT-ECD calculations and X-ray crystallographic analysis. Additionally, we first determined and reported the absolute configuration of the known monoterpenoid pestalotiolactone A (5) through the X-ray crystallographic experiment. All of these isolated compounds were evaluated for antimicrobial activities against human and aquatic pathogenic bacteria. Compounds 1, 2, 6 and 9 exhibited selective inhibitory activities against zoonotic pathogenic bacteria such as Escherichia coli, Edwardsiella tarda, Vibrio anguillarum and V. harveyi, with MIC values ranging from 1.0 to 8.0 µg/mL.
Asunto(s)
Antiinfecciosos/farmacología , Aspergillus/química , Sedimentos Geológicos/microbiología , Animales , Antiinfecciosos/química , Antiinfecciosos/aislamiento & purificación , Cristalografía por Rayos X , Edwardsiella tarda/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Conformación Molecular , Monoterpenos/química , Monoterpenos/aislamiento & purificación , Monoterpenos/farmacología , Agua de Mar/microbiología , Sesquiterpenos/química , Sesquiterpenos/aislamiento & purificación , Sesquiterpenos/farmacología , Vibrio/efectos de los fármacos , Zoonosis/microbiologíaRESUMEN
The overuse of antibiotics to control bacterial pathogens leads to the generation of their antibiotic-resistant strains including Edwardsiella tarda. Understanding of mechanisms of the antibiotic resistance is crucial to develop novel methods to manage the infection. Here, two-dimensional electrophoresis-based proteomics was used to characterize balofloxacin-responsive proteins. The altered proteome consisted of 19 proteins with differential abundance, where six metabolic pathways were enriched. The metabolic modulation activated the central carbon metabolism with elevation of NADH, PMF, and ATP. Among the 19 proteins, ETAE_1987 (pre-peptidase) and ETAE_2174 (integration host factor beta subunit) were bound with balofloxacin directly. This was further confirmed by the binding of balofloxacin with recombinant ETAE_1987 and ETAE_2174 using Oxford cup method. Compared with bovine serum albumin, a known balofloxacin-binding protein, ETAE_1987 and ETAE_2174 increased the binding capability by 3.3- and 22-fold, respectively. The combination was validated by microscale thermophoresis. These data characterize the balofloxacin-stressed proteome as a result of the increased central carbon metabolism and energy metabolism and determine ETAE_1987 and ETAE_2174 as balofloxacin-binding proteins. These findings have significant implications in understanding bacterial antibiotic-resistant and drug action mechanisms based on balofloxacin-binding proteins. SIGNIFICANCE: Antibiotic-resistant Edwardsiella tarda strains are frequently isolated and cause a great loss in aquaculture since these bacterial strains are insensitivity to antibiotics. The present study showed that the increased central carbon metabolism forms a characteristic feature of the balofloxacin-stressed proteomics. Furthermore, two proteins, ETAE_1987 (pre-peptidase) and ETAE_2174, of the balofloxacin-stressed proteome were identified as balofloxacin-binding proteins. The binding capability is 0.39⯱â¯0.017 and 2.67⯱â¯0.066â¯ng/µg proteins for ETAE_1987 and ETAE_2174, respectively. These results reveal the elevated central carbon metabolism as a key feature of the balofloxacin-stressed proteomics and pre-peptidase and integration host factor as balofloxacin-binding proteins in E. tarda. These findings are useful in the understanding of bacterial balofloxacin-stressed mechanisms and providing new targets for controlling antibiotic-resistant bacteria.
Asunto(s)
Proteínas Portadoras/metabolismo , Edwardsiella tarda , Fluoroquinolonas/farmacología , Factores de Integración del Huésped/metabolismo , Péptido Hidrolasas/metabolismo , Proteoma/efectos de los fármacos , Proteínas Portadoras/análisis , Proteínas Portadoras/genética , Farmacorresistencia Bacteriana/genética , Edwardsiella tarda/efectos de los fármacos , Edwardsiella tarda/genética , Edwardsiella tarda/metabolismo , Fluoroquinolonas/metabolismo , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Factores de Integración del Huésped/genética , Péptido Hidrolasas/análisis , Péptido Hidrolasas/genética , Proteoma/genética , Proteoma/metabolismo , Proteómica , Estrés Fisiológico/efectos de los fármacos , Estrés Fisiológico/genéticaRESUMEN
Triclosan (TCS) is a biocide commonly used in household and personal care items to prevent the microbial growth and is currently considered as an emerging pollutant. It has a ubiquitous distribution which can substantially contribute towards antimicrobial resistance. The present study was designed to evaluate the effect of different concentrations of TCS exposure on the antibiotic sensitivity of aquatic bacteria. Aeromonas hydrophila ATCC® 49140™ and Edwardsiella tarda ATCC® 15947™ exposed to TCS for short (30â¯min) and long duration (serial passages). The agar-disc diffusion assay during the serial passages of TCS exposure and subsequent exposure withdrawal showed clinically insignificant changes in the zone of inhibition for six selected antibiotics in both bacterial strains at all exposure concentrations. Four folds concentration-dependent increase in the minimum inhibitory concentrations (MICs) of TCS was observed in both the strains following TCS exposure. Similarly, a concentration-dependent increase in the MICs of oxytetracycline (OTC) up to 4 folds in A. hydrophila, and up to 8 folds in E. tarda, was also documented during the TCS exposure. In all the cases, withdrawal of TCS exposure effectively reduced the MICs of TCS and OTC in blank passages suggesting a decline in acquired resistance. The frequencies of mutation during 30â¯min TCS exposure for E. tarda and A. hydrophila ranged between >10-6 and 10-7 levels. Nevertheless, the TCS exposure did not cause any detectable mutation on the fabV gene of A. hydrophila indicating that the TCS may elicit phenotypic adaptation or other resistance mechanism. Although the reduction in MICs due to exposure withdrawal did not restore the bacterial susceptibility up to the initial level, the study proved that the reduced TCS use could significantly help reduce the antimicrobial-resistance and cross-resistance in pathogenic bacteria.
Asunto(s)
Aeromonas hydrophila/efectos de los fármacos , Antibacterianos/farmacología , Desinfectantes/toxicidad , Farmacorresistencia Bacteriana , Edwardsiella tarda/efectos de los fármacos , Triclosán/toxicidad , Aeromonas hydrophila/genética , Relación Dosis-Respuesta a Droga , Farmacorresistencia Bacteriana/genética , Edwardsiella tarda/genética , Humanos , Pruebas de Sensibilidad Microbiana , Factores de TiempoRESUMEN
Peptidoglycan recognition proteins (PGRPs) are a family of pattern recognition receptors (PRRs) involved in host antibacterial responses, and their functions have been characterized in most invertebrate and vertebrate animals. However, little information is available regarding the function of frog PGRPs. In this study, a short-type PGRP (termed Xl-PGRP-S) gene was identified in the African clawed frog, Xenopus laevis. The predicted protein of Xl-PGRP-S contains several structural features known in PGRPs, including a typical PGRP domain and two closely spaced conserved cysteines. Xl-PGRP-S gene was constitutively expressed in all tissues examined, with the highest expression level observed in muscle. As a typical PRR, Xl-PGRP-S is inducible after peptidoglycan (PGN) stimulation, and has an ability to bind PGN. In addition, Xl-PGRP-S has been proven to have Zn2+-dependent amidase activity and antibacterial activity against Edwardsiella tarda. The present study represents the first discovery on the function of frog PGRPs, thus contributing to a better understanding of the functional evolution of PGRPs in early tetrapods.
Asunto(s)
Proteínas Portadoras/genética , Proteínas de Xenopus/genética , Xenopus laevis/genética , Amidohidrolasas/genética , Amidohidrolasas/metabolismo , Secuencia de Aminoácidos , Animales , Antibacterianos/metabolismo , Antibacterianos/farmacología , Proteínas Portadoras/metabolismo , Proteínas Portadoras/farmacología , Clonación Molecular , ADN Complementario/química , ADN Complementario/genética , Edwardsiella tarda/efectos de los fármacos , Perfilación de la Expresión Génica/métodos , Peptidoglicano/metabolismo , Filogenia , Unión Proteica , Isoformas de Proteínas/clasificación , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Proteínas de Xenopus/metabolismo , Proteínas de Xenopus/farmacología , Xenopus laevis/metabolismo , Zinc/metabolismoRESUMEN
In order to investigate the dynamic distribution of antigen in different tissues post vaccination, an absolute real-time quantitative PCR was employed to detect the amount of antigen in flounder (Paralichthys olivaceus) post intraperitoneal (i.p.) injection with three concentrations (107, 108, 109â¯CFUâ¯ml-1) of formalin-inactivated Edwardsiella tarda bacterin. The results showed that the amount of uptaken antigen quickly increased and then decreased in different tissues. The peak occurred first in the spleen and head kidney at 6-9â¯h after injection, and in the liver and blood at 9-15â¯h, then in the gill, intestine and skin at 15-24â¯h, finally in the muscle at 24-36â¯h. The amount of antigen was highest in the spleen and head kidney, followed by the blood, liver and gill, and lowest in the intestine, skin and muscle. Among the three concentration groups, the amount of antigen increased with the increasing concentration of the vaccine in the blood, liver, gill, intestine, skin and muscle, except for the spleen and head kidney, in which more antigens were found in the 108â¯CFUâ¯ml-1 group than that in 109â¯CFUâ¯ml-1 group. Moreover, IIFA and western blotting was performed to examine the tissue distribution of antigen at 9â¯h after vaccination with 108â¯CFUâ¯ml-1 formalin-inactivated E. tarda. The bacteria were mainly observed in the spleen and head kidney, then the liver, gill and blood, and least in the intestine, skin and muscle, which was roughly in accordance with the results of absolute qPCR. Furthermore, the expressions of CD4-1, MHC IIα, CD8α and MHC Iα in different tissues were detected by RT-qPCR, and the expression levels of these genes were highest in the spleen and head kidney, then in the blood, gill, liver, and lowest in the intestine, skin and muscle. All these results provided useful information for dynamic transportation of antigen uptake post vaccination, and also deepened the understanding of immune response to the injection vaccination.
Asunto(s)
Vacunas Bacterianas/administración & dosificación , Edwardsiella tarda/fisiología , Infecciones por Enterobacteriaceae/veterinaria , Enfermedades de los Peces/prevención & control , Peces Planos , Vacunación/veterinaria , Animales , Edwardsiella tarda/efectos de los fármacos , Infecciones por Enterobacteriaceae/inmunología , Infecciones por Enterobacteriaceae/prevención & control , Enfermedades de los Peces/inmunología , Formaldehído/farmacología , Vacunas de Productos Inactivados/administración & dosificaciónAsunto(s)
Antibacterianos/uso terapéutico , Bacteriemia/microbiología , Edwardsiella tarda/aislamiento & purificación , Infecciones por Enterobacteriaceae/microbiología , Hepatitis C Crónica/complicaciones , Choque Séptico/microbiología , Animales , Programas de Optimización del Uso de los Antimicrobianos , Bacteriemia/diagnóstico , Bacteriemia/tratamiento farmacológico , Bagres/microbiología , Enfermedad Crítica , Edwardsiella tarda/efectos de los fármacos , Infecciones por Enterobacteriaceae/diagnóstico , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Resultado Fatal , Humanos , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Choque Séptico/diagnóstico , Choque Séptico/tratamiento farmacológicoRESUMEN
Four new uncommon 20-nor-isopimarane diterpenoid epimers, aspewentins I-L (1â»4), together with a new methylated derivative of 3, aspewentin M (5), were isolated from the deep sea sediment-derived fungus Aspergillus wentii SD-310. The very similar structures of these epimers made the separation and purification procedures difficult. The structures of compounds 1â»5 were illustrated based on spectroscopic analysis, and the absolute configurations of compounds 1â»5 were unambiguously determined by the combination of NOESY, time-dependent density functional (TDDFT)-ECD calculations, and X-ray crystallographic analysis. These metabolites represented the rare examples of 20-nor-isopimarane analogues possessing a cyclohexa-2,5-dien-1-one moiety. These compounds were tested for antimicrobial activities against human and aquatic pathogenic bacteria, as well as plant-pathogenic fungi. While compounds 1 and 2 exhibited inhibitory activities against zoonotic pathogenic bacteria such as Escherichia coli, Edwardsiella tarda, Vibrio harveyi, and V. parahaemolyticus, compound 5 showed potent activity against the plant pathogen Fusarium graminearum.
Asunto(s)
Antibacterianos/farmacología , Organismos Acuáticos/química , Aspergillus/química , Diterpenos/farmacología , Sedimentos Geológicos/microbiología , Animales , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Artemia/efectos de los fármacos , Cristalografía por Rayos X , Diterpenos/química , Diterpenos/aislamiento & purificación , Edwardsiella tarda/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Fusarium/efectos de los fármacos , Dosificación Letal Mediana , Espectroscopía de Resonancia Magnética , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Estereoisomerismo , Vibrio/efectos de los fármacosRESUMEN
Intramuscular (i.m.) injection is one of the common delivery methods of vaccination in aquaculture, which could induce an ideal immune protection to fish. In the present study, the olive flounders (Paralichthys olivaceus) were injected intramuscularly with 200⯵l of three concentrations of formalin-inactivated Edwardsiella tarda bacterin (107, 108, 109 CFUâ¯ml-1) to investigate the transportation and dynamic distribution of antigen uptake in tissues by absolute real-time quantitative PCR (qPCR). The amount of uptaken antigen increased firstly, and then decreased. The peak occurred first in the blood at 6-9â¯h after i.m. injection, and in the spleen and head kidney at 9-15â¯h, then in the liver, gill and muscle at 15-24â¯h, finally in the skin and intestine at 36â¯h. The amount of uptaken antigen was highest in the head kidney, followed by in the spleen, blood, gill, and liver, and lowest in the muscle, skin and intestine. Among the three dose groups, the amount of uptaken antigen in all tested tissues became higher with the increasing dose of injected bacterin. Moreover, the tissue distribution of antigen uptake was investigated by indirect immunofluorescence assay (IIFA) at 15â¯h after i.m. injection with 200⯵l of 108 CFUâ¯ml-1E. tarda bacterin. The distribution of antigen was mainly observed in the head kidney, then in the spleen, blood, liver, gill and muscle, and least in the skin and intestine, which correlated with the results of absolute qPCR detection. Furthermore, the expression levels of MHC Iα, MHC IIα, CD4-1 and CD8α were detected by RT-qPCR. The expression of these four genes peaked highest in the head kidney, followed by in the spleen, liver, blood and gill, and lowest in the muscle, skin and intestine, and the levels increased in parallel with the increasing dose of injected vaccine. All these results provided an important insight into the dynamic transportation of antigen uptake, and also deepened the understanding of immune response to the i.m. injection.
Asunto(s)
Edwardsiella tarda , Infecciones por Enterobacteriaceae/veterinaria , Lenguado/microbiología , Animales , Antígenos Bacterianos/administración & dosificación , Antígenos Bacterianos/metabolismo , Edwardsiella tarda/efectos de los fármacos , Infecciones por Enterobacteriaceae/microbiología , Lenguado/inmunología , Técnica del Anticuerpo Fluorescente Indirecta/veterinaria , Formaldehído/farmacología , Inyecciones Intramusculares/veterinaria , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/veterinariaRESUMEN
The emergence and ongoing spread of multidrug-resistant bacteria puts humans and other species at risk for potentially lethal infections. Thus, novel antibiotics or alternative approaches are needed to target drug-resistant bacteria, and metabolic modulation has been documented to improve antibiotic efficacy, but the relevant metabolic mechanisms require more studies. Here, we show that glutamate potentiates aminoglycoside antibiotics, resulting in improved elimination of antibiotic-resistant pathogens. When exploring the metabolic flux of glutamate, it was found that the enzymes that link the phosphoenolpyruvate (PEP)-pyruvate-AcCoA pathway to the TCA cycle were key players in this increased efficacy. Together, the PEP-pyruvate-AcCoA pathway and TCA cycle can be considered the pyruvate cycle (P cycle). Our results show that inhibition or gene depletion of the enzymes in the P cycle shut down the TCA cycle even in the presence of excess carbon sources, and that the P cycle operates routinely as a general mechanism for energy production and regulation in Escherichia coli and Edwardsiella tarda These findings address metabolic mechanisms of metabolite-induced potentiation and fundamental questions about bacterial biochemistry and energy metabolism.
Asunto(s)
Aminoglicósidos/farmacología , Antibacterianos/farmacología , Edwardsiella tarda/efectos de los fármacos , Edwardsiella tarda/metabolismo , Escherichia coli/efectos de los fármacos , Escherichia coli/metabolismo , Ácido Pirúvico/metabolismo , Ciclo del Ácido Cítrico/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Fosfoenolpiruvato/metabolismoRESUMEN
Hepcidins are small cysteine-rich antimicrobial peptides that play an important role in fish immunity against pathogens. Most fish species have two or more hepcidin homologs that have distinct functions. This study investigated the immune functions of mudskipper (Boleophthalmus pectinirostris) hepcidin-1 (BpHep-1) and hepcidin-2 (BpHep-2) in vitro and in vivo. Upon infection with Edwardsiella tarda, the expression of BpHep-1 and BpHep-2 mRNA in immune tissues was significantly upregulated, but the expression profiles were different. Chemically synthesized BpHep-1 and BpHep-2 mature peptides exhibited selective antibacterial activity against various bacterial species, and BpHep-2 exhibited a stronger antibacterial activity and broader spectrum than BpHep-1. BpHep-1 and BpHep-2 both inhibited the growth of E. tarda in vitro, with the latter being more effective than the former. In addition, both peptides induced hydrolysis of purified bacterial genomic DNA (gDNA) or gDNA in live bacteria. In vivo, an intraperitoneal injection of 1.0 µg/g BpHep-2 significantly improved the survival rate of mudskippers against E. tarda infection compared with 0.1 µg/g BpHep-2 or 0.1 and 1.0 µg/g BpHep-1. Similarly, only BpHep-2 treatment effectively reduced the tissue bacterial load in E. tarda-infected mudskippers. Furthermore, treatment with 1.0 or 10.0 µg/ml BpHep-2 promoted the phagocytic and bactericidal activities of mudskipper monocytes/macrophages (MO/MФ). However, only the highest dose (10.0 µg/ml) of BpHep-1 enhanced phagocytosis, and BpHep-1 exerted no obvious effects on bactericidal activity. In conclusion, BpHep-2 is a stronger bactericide than BpHep-1 in mudskippers, and acts not only by directly killing bacteria but also through an immunomodulatory function on MO/MФ.
Asunto(s)
Edwardsiella tarda/efectos de los fármacos , Infecciones por Enterobacteriaceae/veterinaria , Enfermedades de los Peces/inmunología , Proteínas de Peces/inmunología , Hepcidinas/genética , Hepcidinas/inmunología , Animales , Edwardsiella tarda/crecimiento & desarrollo , Edwardsiella tarda/fisiología , Infecciones por Enterobacteriaceae/genética , Infecciones por Enterobacteriaceae/inmunología , Infecciones por Enterobacteriaceae/microbiología , Enfermedades de los Peces/genética , Enfermedades de los Peces/microbiología , Proteínas de Peces/genética , Proteínas de Peces/farmacología , Peces , Hepcidinas/síntesis química , Hepcidinas/farmacología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Fagocitosis/efectos de los fármacosRESUMEN
Edwardsiella tarda is a Gram-negative bacterium that can infect a broad range of hosts including humans and fish. Accumulating evidences have indicated that E. tarda is able to survive and replicate in host phagocytes. However, the pathways involved in the intracellular infection of E. tarda are unclear. In this study, we examined the entry and endocytic trafficking of E. tarda in the mouse macrophage cell line RAW264.7. We found that E. tarda entered RAW264.7 and multiplied intracellularly in a robust manner. Cellular invasion of E. tarda was significantly impaired by inhibition of clathrin- and caveolin-mediated endocytic pathways and by inhibition of endosome acidification, but not by inhibition of macropinocytosis. Consistently, RAW264.7-infecting E. tarda was co-localized with clathrin, caveolin, and hallmarks of early and late endosomes, and intracellular E. tarda was found to exist in acid organelles. In addition, E. tarda in RAW264.7 was associated with actin and microtubule, and blocking of the functions of these cytoskeletons by inhibitors significantly decreased E. tarda infection. Furthermore, formaldehyde-killed E. tarda exhibited routes of cellular uptake and intracellular trafficking similar to that of live E. tarda. Together these results provide the first evidence that entry of live E. tarda into macrophages is probably a passive, virulence-independent process of phagocytosis effected by clathrin- and caveolin-mediated endocytosis and cytoskeletons, and that the intracellular traffic of E. tarda involves endosomes and endolysosomes.